OverviewChartNewsTraderScreen

Essex Bio-Technology Ltd/  KYG312371035  /

Hong Kong SE
2024-04-25  9:48:42 AM Chg. +0.01 Volume Bid9:48:43 AM Ask10:01:02 AM High Low
2.19HKD +0.46% 171,000
Turnover: 373,870		 2.19Bid Size: 1,000 2.21Ask Size: 11,000 2.20 2.18
GlobeNewswire 2019-03-29 AC Immune Presents New Data on Alpha-Synuclein PET Tracer at AD/PD™ Conference
GlobeNewswire 2019-03-21 AC Immune Reports Full-Year 2018 Financial Results and Provides Business Update
GlobeNewswire 2019-03-04 AC Immune to Report Progress of Early-Stage Pipeline at AD/PD™ Congress
GlobeNewswire 2019-02-20 AC Immune Announces Anti-Tau Monoclonal Antibody Entering Second Phase 2 Trial in Moderate Alzheimer...
GlobeNewswire 2019-02-07 AC Immune Makes Two Appointments to Executive Committee to Accelerate Product Development
GlobeNewswire 2019-01-03 AC Immune Announces Appointment of Dr. Marie Kosco-Vilbois as Chief Scientific Officer
GlobeNewswire 2018-12-19 AC Immune and WuXi Biologics to Establish an Exclusive Strategic Partnership
GlobeNewswire 2018-12-07 In Memoriam: Dr. Andreas Muhs CSO, Scientific Leader and Friend has Passed Away
GlobeNewswire 2018-11-15 AC Immune Awarded Third Follow-up Grant from The Michael J. Fox Foundation for First-in-Human Study ...
GlobeNewswire 2018-11-13 AC Immune Reports Third Quarter 2018 Financial Results and Corporate Update
GlobeNewswire 2018-11-01 AC Immune to Present at 2018 Society for Neurosciences Meeting
GlobeNewswire 2018-10-22 AC Immune Announces Dr. Andreas Muhs, Chief Scientific Officer, to Take Medical Leave of Absence
GlobeNewswire 2018-09-19 Antibody Discovery Services and Platforms Market, 2028
GlobeNewswire 2018-08-20 AC Immune Announces Important Clinical Milestones for ACI-24 Vaccine in Alzheimer's Disease and Dow...
GlobeNewswire 2018-08-08 AC Immune Reports Second Quarter 2018 Financial Results and Corporate Update
GlobeNewswire 2018-07-25 New Phase 2 Data Analysis for Crenezumab Presented at Global Alzheimer's Conference Provides Strong ...
GlobeNewswire 2018-07-17 Crenezumab's Second Phase 3 Trial (CREAD 2) Fully Recruited - Updates on AC Immune's Pipeline and Te...
GlobeNewswire 2018-07-06 AC Immune Announces Results of Annual General Meeting
GlobeNewswire 2018-05-02 AC Immune Reports First Quarter 2018 Financial Results and Corporate Update
GlobeNewswire 2018-04-27 AC Immune Announces Results of Extraordinary Shareholders Meeting
GlobeNewswire 2018-04-05 AC Immune Announces the Selection of Tau Small Molecules for Clinical Development in Alzheimer's dis...
GlobeNewswire 2018-03-20 AC Immune reports full-year 2017 financial results - successful first year as a public company
GlobeNewswire 2018-03-15 AC Immune prepares for a first in human study of a promising positron emission tomography (PET) trac...
GlobeNewswire 2018-02-06 AC Immune to Participate in Two Investor Conferences and Provide Scientific Updates at AAT-AD/PD Con...
GlobeNewswire 2017-12-01 AC Immune Shares Insights from Key Opinion Leader Meeting on Tau as a Therapeutic and Diagnostic Tar...